Telaprevir Experience From Turkey
HEPATITIS MONTHLY, cilt.15, sa.2, 2015 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 15 Sayı: 2
- Basım Tarihi: 2015
- Doi Numarası: 10.5812/hepatmon.25639
- Dergi Adı: HEPATITIS MONTHLY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Çukurova Üniversitesi Adresli: Evet
Özet
Background: In patients with chronic hepatitis C, triple drug regimens containing a protease inhibitor, peginterferon and ribavirin were found to significantly increase sustained virologic response rates compared to dual drug regimen containing pegylated interferon and ribavirin, especially in genotype 1.